References
- Ali, M. M., Dowd, W. N., Classen, T., Mutter R., & Novak, S. P. (2017). Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health. Addictive Behaviors, 69, 65–77.
- Blum, C. J., Nelson, L. S., & Hoffman, R. S. (2016). A survey of physicians’ perspectives on the New York State Mandatory Prescription Monitoring Program (ISTOP). Journal of Substance Abuse Treatment, 70, 35–43.
- Brown, R., Riley, M. R., Ulrich, L., Kraly, E. P., Jenkins, P., Krupa, N. L., & Gadomski, A. (2017). Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity. Drug and Alcohol Dependence, 178, 348–354.
- Florence, C. S., Zhou, C., Luo, F., & Xu, L. (2016). The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Medical Care, 54(10), 901–906.
- Haffajee, R. L., Jena, A. B., & Weiner, S. G. (2015). Mandatory use of prescription drug monitoring programs. JAMA, 313(9), 891–892.
- Li, G., Brady, J. E., Lang, B. H., Giglio, J., Wunsch, H., & DiMaggio, C. (2014). Prescription drug monitoring and drug overdose mortality. Injury Epidemiology, 1(1), 9.
- Lin, D. H., Lucas, E., Murimi, I. B., Jackson, K., Baier, M., Frattaroli, S., … Alexander, G. C. (2017). Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP). Addiction, 112(2), 311–319.
- Lin, H. C., Wang, Z., Boyd, C., Simoni-Wastila, L., & Buu, A. (2018). Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain. Addictive Behaviors, 76, 348–354.
- McAlister, M. W., Aaronson, P., Spillane, J., Schreiber, M., Baroso, G., Kraemer, D., … Gray-Eurom, K. (2015). Impact of prescription drug-monitoring program on controlled substance prescribing in the ED. The American Journal of Emergency Medicine, 33(6), 781–785. Jun
- Morone, N. E., & Weiner, D. K. (2013). Pain as the fifth vital sign: exposing the vital need for pain education. Clinical Therapeutics, 35(11), 1728–1732.
- Muhuri, P. K., Gfroerer, J. C., & Davies, M. C. (2013). Substance Abuse and Mental Health Services Administration. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review. Retrieved from: http://www.samhsa.gov/data/2k13/DataReview/DR006/nonmedical-pain-reliever-use-2013.pdf
- Poon, S. J., Greenwood-Ericksen, M. B., Gish, R. E., Neri, P. M., Takhar, S. S., Weiner, S. G., … Landman, A. B. (2016). Usability of the Massachusetts prescription drug monitoring program in the emergency department: A mixed-methods study. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine, 23(4), 406–414.
- R Core Team. (2016). A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Released 2012.
- Vowles, K. E., McEntee, M. L., Julnes, P. S., Frohe, T., Ney, J. P., & van der Goes, D. N. (2015). Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain, 156(4), 569–576.
- Young, H. W., 2nd, Tyndall, J. A., & Cottler, L. B. (2017). The current utilization and perceptions of prescription drug monitoring programs among emergency medicine providers in Florida. International Journal of Emergency Medicine, 10(1), 16.